
InterMune has ended a year-long legal spat with the European Medicines Agency over the potential release of data for its …

InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …
The first ever treatment for the potentially fatal lung disease idiopathic pulmonary fibrosis (IPF) has been approved in the EU. …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

